Heron Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HRTX and other ETFs, options, and stocks.

About HRTX

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. 

CEO
Craig A. Collard
CEOCraig A. Collard
Employees
128
Employees128
Headquarters
Cary, North Carolina
HeadquartersCary, North Carolina
Founded
1983
Founded1983
Employees
128
Employees128

HRTX Key Statistics

Market cap
64.74M
Market cap64.74M
Price-Earnings ratio
-1.77
Price-Earnings ratio-1.77
Dividend yield
Dividend yield
Average volume
3.82M
Average volume3.82M
High today
$0.35
High today$0.35
Low today
$0.3282
Low today$0.3282
Open price
$0.34
Open price$0.34
Volume
1.76M
Volume1.76M
52 Week high
$1.58
52 Week high$1.58
52 Week low
$0.303
52 Week low$0.303

Stock Snapshot

As of today, Heron Therapeutics(HRTX) shares are valued at $0.35. The company's market cap stands at 64.74M, with a P/E ratio of -1.77.

As of 2026-08-15, Heron Therapeutics(HRTX) stock has fluctuated between $0.33 and $0.35. The current price stands at $0.35, placing the stock +6.6% above today's low and 0.0% off the high.

Heron Therapeutics(HRTX) shares are trading with a volume of 1.76M, against a daily average of 3.82M.

In the last year, Heron Therapeutics(HRTX) shares hit a 52-week high of $1.58 and a 52-week low of $0.30.

In the last year, Heron Therapeutics(HRTX) shares hit a 52-week high of $1.58 and a 52-week low of $0.30.

HRTX News

TipRanks 20h
Heron Therapeutics Extends Tax Benefit Preservation Plan Timeline

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

TipRanks 4d
Heron Therapeutics Faces Nasdaq Delisting Risk as Share Price Falls Below $1 Threshold

Heron Therapeutics Inc (HRTX) has disclosed a new risk, in the Share Price & Shareholder Rights category. Unlock powerful investing tools with TipRanks Premium...

Investing.com 5d
Heron Therapeutics earnings missed by $0.02, revenue fell short of estimates - Investing.com

...

Heron Therapeutics earnings missed by $0.02, revenue fell short of estimates - Investing.com

People also own

Based on the portfolios of people who own HRTX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.